Pfizer Incorporated
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 19.20 |
| 52 Week High | 25.71 |
| 52 Week Low | 17.12 |
| Avg. Daily Vol. (Mil) | 43.68 |
| Beta (3 year) | 0.78 |
| Share Related Items | |
| Mkt Cap (Mil) | 129,427.09 |
| Shares Out (Mil) | 6,740.99 |
| Float (Mil) | 6,736.00 |
| Dividend Information | |
| Yield % | 6.70 |
| Annual Dividend | 1.28 |
| Payout Ratio | 92.00 |
| Financial Strength | |
| Quick Ratio | 1.60 |
| Current Ratio | 2.10 |
| LT Debt/ Equity | 0.11 |
| Total Debt / Equity | 0.25 |
| Valuation Ratios | |
| Price Earnings | 14.50 |
| Price/Sales | 2.65 |
| Price/Book | 1.95 |
| Price/Cash Flow | 9.10 |
| Per Share Data | |
| Earnings | 1.32 |
| Sales | 7.24 |
| Book Value | 9.86 |
| Cash Flow | 2.11 |
| Business Summary | |
|---|---|
| A research-based, global pharmaceutical company which discovers, develops, manufactures and markets prescription medicines for humans and animals. | |
| General Information | |
| 235 East 42nd Street
New York, NY 10017 |
|
| www.pfizer.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 86600 | |
| CEO: Jeffrey B. Kindler | |
| Short Interest | |
| Current Month (Mil) | 64.29 |
| Previous Month (Mil) | 65.34 |
| Short Interest Ratio (Days) | 1.40 |
| Management Effectiveness | |
| Return on Equity | 13.60 |
| Return on Assets | 7.80 |
| Return on Investments | 12.30 |
| Profitability | |
| Gross Margin | 81.00 |
| EBIT Margin | 21.20 |
| Profit Margin | 18.50 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas